You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
吉藥控股(300108.SZ):公司控股股東將變更為本草匯醫藥 實控人將變更為劉舒
格隆匯 11-12 19:33

格隆匯 11 月 12日丨吉藥控股(300108.SZ)公佈,2020年11月12日,公司收到控股股東及實際控制人盧忠奎與吉林省本草匯醫藥科技有限公司(“本草匯醫藥”)簽訂的《吉林省本草匯醫藥科技有限公司與盧忠奎關於吉藥控股集團股份有限公司股份轉讓之股份轉讓協議》(“《股份轉讓協議》”)及《盧忠奎、黃克鳳與吉林省本草匯醫藥科技有限公司關於吉藥控股集團股份有限公司之表決權委託協議》(“《表決權委託協議》”),將涉及公司控制權變更。

公司控股股東及實際控制人盧忠奎於2020年11月12日與吉林省本草匯醫藥科技有限公司簽署了《股份轉讓協議》,約定盧忠奎將其持有的上市公司股份約3330.07萬股(占上市公司總股本的比例為5.00%)在《股份轉讓協議》約定的條件成就時轉讓給本草匯醫藥。

盧忠奎和黃克鳳與本草匯醫藥簽署了《表決權委託協議》,盧忠奎及黃克鳳擬將其合計持有的上市公司剩餘128,083,246股股份(占上市公司股份總數的19.23%)對應的表決權全權不可撤銷的委託本草匯醫藥行使。

此次股份轉讓完成後,本草匯醫藥將持有公司約3330.07萬股股份,佔公司總股本5.00%,合計享有公司24.23%表決權,公司的控股股東變更為本草匯醫藥,實際控制人變更為劉舒。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account